Ray (Diagnostic Equipment) Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
186
- Stock Symbol
-
228670
- Investments
-
7
- Share Price
-
$3.01
- (As of Friday Closing)
Ray (Diagnostic Equipment) General Information
Description
Ray Co Ltd is a South Korea based company engaged in providing x-ray imaging solutions in dental & medical industry. The product portfolio of the company include 3-in-1 CBCT RAYSCAN series for dental and medical, IP scanner RIOScan, intraoral sensor RIOSensor and software solutions.
Contact Information
Website
www.raymexico.comCorporate Office
- 12 Floor, Twosun World Building, 221
- Pangyoyeok-ro, Bundang-gu
- Seongnam-si, Gyeonggi-do 13494
- South Korea
Corporate Office
- 12 Floor, Twosun World Building, 221
- Pangyoyeok-ro, Bundang-gu
- Seongnam-si, Gyeonggi-do 13494
- South Korea
Ray (Diagnostic Equipment) Timeline
Ray (Diagnostic Equipment) Stock Performance
As of 13-Nov-2026, Ray (Diagnostic Equipment)’s stock price is $3.01. Its current market cap is $47M with 15.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.01 | $2.99 | $2.55 - $7.90 | $47M | 15.6M | 52K | $0.42 |
Ray (Diagnostic Equipment) Financials Summary
As of 30-Jun-2026, Ray (Diagnostic Equipment) has a trailing 12-month revenue of $82.1M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 59,726 | 106,221 | 114,471 | 311,376 |
| Revenue | 82,116 | 78,224 | 58,517 | 111,577 |
| EBITDA | 15,197 | 11,694 | (31,513) | 5,477 |
| Net Income | 6,635 | 2,205 | (44,287) | (1,642) |
| Total Assets | 114,864 | 133,499 | 138,642 | 201,410 |
| Total Debt | 41,917 | 56,014 | 57,995 | 67,262 |
Ray (Diagnostic Equipment) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ray (Diagnostic Equipment) Patents
Ray (Diagnostic Equipment) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026054257-A1 | Method, device, and computer program for generating model for fabricating temporary denture of edentulous patient | Pending | 03-Sep-2024 | ||
| WO-2025170194-A1 | Method and apparatus for generating periodontal data | Pending | 06-Feb-2024 | ||
| JP-2026504183-A | Method and apparatus for generating dental alignment data | Active | 21-Mar-2023 | ||
| JP-7869615-B2 | Method and apparatus for generating dental consistency data | Active | 21-Mar-2023 | ||
| EP-4640155-A1 | Method for generating dental alignment data | Active | 21-Mar-2023 | G06T7/10 |
Ray (Diagnostic Equipment) Signals
Ray (Diagnostic Equipment) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ray (Diagnostic Equipment) Investments & Acquisitions (7)
Ray (Diagnostic Equipment)’s most recent deal was a Later Stage VC with CellArtgen for . The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CellArtgen | 01-Dec-2025 | Later Stage VC | Biotechnology | ||
| Oneday Biotech | 08-Mar-2023 | Corporate | Medical Supplies | ||
| Nexstar Technology (9 Apartments in Yongin, South Korea) | 30-Jul-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Seers (Monitoring Equipment) | 14-May-2022 | Later Stage VC | Monitoring Equipment | ||
| Didis | 01-Jan-2021 | Merger/Acquisition | Diagnostic Equipment |
Ray (Diagnostic Equipment) ESG
Risk Overview
Risk Rating
Updated April, 30, 2024
36.8 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,216
Rank
Percentile
Healthcare
Industry
of 643
Rank
Percentile
Medical Devices
Subindustry
of 229
Rank
Percentile
Ray (Diagnostic Equipment) Exits (1)
Ray (Diagnostic Equipment)’s most recent exit was on 14-May-2022 from Seers (Monitoring Equipment). The exit was categorized as with 8 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Seers (Monitoring Equipment) | 14-May-2022 | Completed |
|
Ray (Diagnostic Equipment) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RayDent | Seoul, South Korea | 2014 |
Ray (Diagnostic Equipment) FAQs
-
When was Ray (Diagnostic Equipment) founded?
Ray (Diagnostic Equipment) was founded in 2004.
-
Where is Ray (Diagnostic Equipment) headquartered?
Ray (Diagnostic Equipment) is headquartered in Seongnam-si, South Korea.
-
What is the size of Ray (Diagnostic Equipment)?
Ray (Diagnostic Equipment) has 186 total employees.
-
What industry is Ray (Diagnostic Equipment) in?
Ray (Diagnostic Equipment)’s primary industry is Diagnostic Equipment.
-
Is Ray (Diagnostic Equipment) a private or public company?
Ray (Diagnostic Equipment) is a Public company.
-
What is Ray (Diagnostic Equipment)’s stock symbol?
The ticker symbol for Ray (Diagnostic Equipment) is 228670.
-
What is the current stock price of Ray (Diagnostic Equipment)?
As of 13-Nov-2026 the stock price of Ray (Diagnostic Equipment) is $3.01.
-
What is the current market cap of Ray (Diagnostic Equipment)?
The current market capitalization of Ray (Diagnostic Equipment) is $47M.
-
What is Ray (Diagnostic Equipment)’s current revenue?
The trailing twelve month revenue for Ray (Diagnostic Equipment) is $82.1M.
-
What is Ray (Diagnostic Equipment)’s annual earnings per share (EPS)?
Ray (Diagnostic Equipment)’s EPS for 12 months was $0.42.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process